GlassScriptPhysician profile
Alexander Philips
NPI 1528059193
$2,146.83
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,527 · 2020: $218 · 2021: $402.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $473.14 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $298.57 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $206.39 | 2019-2021 | |
| Eisai INC. | $166.95 | 2019 | |
| Mallinckrodt Hospital Products INC. | $125.00 | 2020 | |
| Glaxosmithkline, LLC. | $125.00 | 2021 | |
| Celgene Corporation | $124.93 | 2021 | |
| Astellas Pharma US INC | $119.33 | 2019 | |
| Merck Sharp & Dohme LLC | $114.94 | 2019 | |
| Kci USA, INC. | $114.45 | 2019 | |
| Sunovion Pharmaceuticals INC. | $108.80 | 2019 | |
| Amgen INC. | $92.83 | 2020 | |
| Misonix INC | $41.81 | 2021 | |
| Smith+Nephew, INC. | $34.69 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Philips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.